CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Wednesday reported a second-quarter loss of $8.9 million, after reporting a profit in the same period a year earlier.
The Cambridge, Massachusetts-based company said it had a loss of 3 cents per share. Losses, adjusted for restructuring costs, came to 2 cents per share.
The kidney disease treatment developer posted revenue of $49.1 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $1.29. A year ago, they were trading at $3.72.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
/An%20image%20of%20the%20Snowflake%20logo%20on%20a%20corporate%20office_%20Image%20by%20Grand%20Warszawski%20via%20Shutterstock_.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)